These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Doxorubicin derivative loaded acetal-PEG-PCCL micelles for overcoming multidrug resistance in MCF-7/ADR cells. Zhong XC, Xu WH, Wang ZT, Guo WW, Chen JJ, Guo NN, Wang TT, Lin MT, Zhang ZT, Lu YY, Yang QY, Han M, Xu DH, Gao JQ. Drug Dev Ind Pharm; 2019 Sep; 45(9):1556-1564. PubMed ID: 31271317 [Abstract] [Full Text] [Related]
5. Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance. Wang J, Sun J, Chen Q, Gao Y, Li L, Li H, Leng D, Wang Y, Sun Y, Jing Y, Wang S, He Z. Biomaterials; 2012 Oct; 33(28):6877-88. PubMed ID: 22770799 [Abstract] [Full Text] [Related]
8. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin. Qiu L, Qiao M, Chen Q, Tian C, Long M, Wang M, Li Z, Hu W, Li G, Cheng L, Cheng L, Hu H, Zhao X, Chen D. Biomaterials; 2014 Dec; 35(37):9877-9887. PubMed ID: 25201738 [Abstract] [Full Text] [Related]
11. Nanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancer. Gu Y, Li J, Li Y, Song L, Li D, Peng L, Wan Y, Hua S. Int J Nanomedicine; 2016 Dec; 11():5757-5770. PubMed ID: 27843316 [Abstract] [Full Text] [Related]
12. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro. Wang Y, Guo M, Lu Y, Ding LY, Ron WT, Liu YQ, Song FF, Yu SQ. Nanotechnology; 2012 Dec 14; 23(49):495103. PubMed ID: 23149859 [Abstract] [Full Text] [Related]
14. Mixed Micelles of Doxorubicin Overcome Multidrug Resistance by Inhibiting the Expression of P-Glycoprotein. Jin Y, Zhang Z, Zhao T, Liu X, Jian L. J Biomed Nanotechnol; 2015 Aug 14; 11(8):1330-8. PubMed ID: 26295136 [Abstract] [Full Text] [Related]
15. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance. Zhao P, Li L, Zhou S, Qiu L, Qian Z, Liu X, Cao X, Zhang H. Mater Sci Eng C Mater Biol Appl; 2018 Mar 01; 84():108-117. PubMed ID: 29519418 [Abstract] [Full Text] [Related]
17. A pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy. Xiong S, Wang Z, Liu J, Deng X, Xiong R, Cao X, Xie Z, Lei X, Chen Y, Tang G. Colloids Surf B Biointerfaces; 2019 Jan 01; 173():346-355. PubMed ID: 30316081 [Abstract] [Full Text] [Related]
20. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance. Guo Y, Chu M, Tan S, Zhao S, Liu H, Otieno BO, Yang X, Xu C, Zhang Z. Mol Pharm; 2014 Jan 06; 11(1):59-70. PubMed ID: 24229050 [Abstract] [Full Text] [Related] Page: [Next] [New Search]